- Projects & figures
- News & Events
- Managing your project
- About ERC
Honey bees are an important species for ecology and economy, but their population has shrank worryingly. Prof. Philipp Engel focuses on gut microbiota, a critical factor for bee health, to understand how it evolved and diversified over time. His study addresses timely questions about evolution, ecology, microbiology and could eventually contribute to new strategies for managing bee colonies’ health.
Key nutrients can improve vision both in ageing and in healthy eyes, according to EU-funded research. Doctors are now prescribing supplements of these nutrients, while the researchers are investigating other possible health benefits.
An EU-funded project is exploring what keeps people committed to a task even when they get bored, distracted or are tempted to stop. The findings could foster productivity-boosting strategies, improve robot-human interactions and even help treat borderline personality disorder.
ERC grantee Erik van Sebille is developing advanced modelling tools to help assess the full extent of the problem of plastic pollution in our oceans and how it is affecting the marine environment. The tools will help policymakers design targeted measures to address a big and growing issue.
Prof. Gregoire Courtine believes paralysed patients will be able to walk again. This belief has represented the focus of years of work aimed at regenerating the functions of the spinal cord after injury. Thanks to his ERC funding in both 2010 and 2015, Prof. Courtine and his team have been able to develop so-called “personalised neuroprosthetics” that have led immobile rats, and more recently monkeys, to overcome their paralysis.
Social networking platforms and other online activities can enable women migrants to maintain the links with their home countries, but also to connect to each other, thus encouraging their emancipation. Digital media could hence be rethought as a tool for participation and integration. These are preliminary findings of Prof. Sandra Ponzanesi’s study focusing on migrant women in three different European countries.
More than 3.5 million new people are diagnosed with heart failure every year in Europe, with a long-term prognosis of 50% mortality within four years. There is urgent need for more innovative, regenerative therapies with the potential to change the course of the condition.
How close are we to developing a successful and comprehensive vaccine for cancer? ERC grantee Prof. Yvette van Kooyk thinks that a combination of glycobiology and immunology will lead us closer than ever before. Thanks to her ground-breaking multidisciplinary team and her new approach based on sugar receptors, she has developed a nanovaccine that promises to represent the future for cancer treatment.
Malaria has always been the centre of attention for Dr Ali Salanti’s, a molecular parasitologist and an ERC grantee. With his studies, he hoped to bring new insight into pregnancy-associated malaria, to save the lives of women and their babies in areas affected by the disease. Now, Dr Salanti’s research has shifted to battling against another deadly disease: cancer. This comes after an unexpected discovery yielded ground-breaking results for the diagnosis and treatment of this illness. This is the kind of curiosity-driven research that can lead to ground-breaking serendipitous outcomes.
We are living longer and, understandably, we wish to be in better health as we age. It is estimated that by 2050 the number of people aged 65 and over will reach 16% of the global population. Medical science has an ever-growing arsenal of drugs it can use to treat an increasing range of conditions. Yet, these drugs are not acting as effectively as their potential promises. Dr. Armağan Koçer and her research team at the University of Groningen (The Netherlands) are using their ERC funding to tackle the following puzzle: how can we develop methods of drug delivery that are as revolutionary as the medicine they contain?